Pro-Dex, Inc.
PDEXNASDAQHealthcare● Active
$65.00
$-0.21(-0.32%)
Market Cap$207529400
P/E Ratio—
52W High$68.99
52W Low$23.47
Pro-Dex, Inc. (PDEX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PDEX · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$1.20
Est. $0.62 · +93.5%
Revenue
$0.02B
Est. $0.02B · +11.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 3-Quarter EPS Beat Streak
PDEX reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $0.86B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$0.86B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 3, 2026 | $0.67 | — | — | — | $0.02B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $0.62 | $1.20 | +93.5% | $0.02B | $0.02B | +11.4% |
| ▲ Q1 FY2026 | Jan 29, 2026 | $0.59 | $0.66 | +11.9% | $0.02B | $0.02B | +7.9% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $0.50 | $0.62 | +24.0% | $0.02B | $0.02B | +21.1% |
| ▼ Q3 FY2025 | Sep 4, 2025 | $0.47 | $0.36 | -23.4% | $0.02B | $0.02B | +14.3% |
| ▲ Q2 FY2025 | May 1, 2025 | $0.47 | $0.98 | +108.5% | $0.02B | $0.02B | -2.7% |
| ▲ Q1 FY2025 | Jan 30, 2025 | $0.38 | $0.61 | +60.5% | $0.02B | $0.01B | +21.7% |
| ▲ Q4 FY2024 | Oct 31, 2024 | $0.29 | $0.75 | +158.6% | $0.01B | $0.01B | +17.3% |
Q3 FY2026
Sep 3, 2026
EPS Actual
—
EPS Est.
$0.67
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$1.20
EPS Est.
$0.62
EPS Surpr.
+93.5%
Revenue
$0.02B
Q1 FY2026
Jan 29, 2026Beat
EPS Actual
$0.66
EPS Est.
$0.59
EPS Surpr.
+11.9%
Revenue
$0.02B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$0.62
EPS Est.
$0.50
EPS Surpr.
+24.0%
Revenue
$0.02B
Q3 FY2025
Sep 4, 2025Miss
EPS Actual
$0.36
EPS Est.
$0.47
EPS Surpr.
-23.4%
Revenue
$0.02B
Q2 FY2025
May 1, 2025Beat
EPS Actual
$0.98
EPS Est.
$0.47
EPS Surpr.
+108.5%
Revenue
$0.02B
Q1 FY2025
Jan 30, 2025Beat
EPS Actual
$0.61
EPS Est.
$0.38
EPS Surpr.
+60.5%
Revenue
$0.02B
Q4 FY2024
Oct 31, 2024Beat
EPS Actual
$0.75
EPS Est.
$0.29
EPS Surpr.
+158.6%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2027 | $0.70 | $0.70 | $0.70 | 1 |
| Q1 FY2027 | $0.74 | $0.74 | $0.74 | 1 |
| Q4 FY2026 | $0.69 | $0.69 | $0.69 | 1 |
| Q3 FY2026 | $0.66 | $0.66 | $0.66 | 1 |
| Q2 FY2026 | $0.67 | $0.67 | $0.67 | 1 |
| Q1 FY2026 | $0.62 | $0.62 | $0.62 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +93.5% | $49.84 | $50.14 | +0.60% |
| ▲ Q1 FY2026 | Jan 29, 2026 | +11.9% | $39.42 | $39.41 | -0.03% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +24.0% | $30.71 | $30.63 | -0.26% |
| ▼ Q3 FY2025 | Sep 4, 2025 | -23.4% | $46.47 | $45.74 | -1.57% |
| ▲ Q2 FY2025 | May 1, 2025 | +108.5% | $65.68 | $67.30 | +2.47% |
| ▲ Q1 FY2025 | Jan 30, 2025 | +60.5% | $43.26 | $42.95 | -0.72% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +158.6% | $30.50 | $31.02 | +1.70% |
| ▲ Q3 FY2024 | Sep 5, 2024 | +31.4% | $22.10 | $22.26 | +0.72% |
Q2 FY2026+0.60%
Report Date
Apr 30, 2026
EPS Beat/Miss
+93.5%
Price Before
$49.84
Price After
$50.14
Q1 FY2026-0.03%
Report Date
Jan 29, 2026
EPS Beat/Miss
+11.9%
Price Before
$39.42
Price After
$39.41
Q4 FY2025-0.26%
Report Date
Oct 30, 2025
EPS Beat/Miss
+24.0%
Price Before
$30.71
Price After
$30.63
Q3 FY2025-1.57%
Report Date
Sep 4, 2025
EPS Beat/Miss
-23.4%
Price Before
$46.47
Price After
$45.74
Q2 FY2025+2.47%
Report Date
May 1, 2025
EPS Beat/Miss
+108.5%
Price Before
$65.68
Price After
$67.30
Q1 FY2025-0.72%
Report Date
Jan 30, 2025
EPS Beat/Miss
+60.5%
Price Before
$43.26
Price After
$42.95
Q4 FY2024+1.70%
Report Date
Oct 31, 2024
EPS Beat/Miss
+158.6%
Price Before
$30.50
Price After
$31.02
Q3 FY2024+0.72%
Report Date
Sep 5, 2024
EPS Beat/Miss
+31.4%
Price Before
$22.10
Price After
$22.26
Avg Beat Reaction+0.64%
Avg Miss Reaction-1.57%
Beat Rate7 / 8 quarters
Largest Move+2.47% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PDEX ends December
Pro-Dex, Inc. (PDEX) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $1.20 — beating the analyst consensus of $0.62 by +93.5%. PDEX has beaten EPS estimates for 3 consecutive quarters. The next PDEX earnings date is expected around September 1, 2026.
Each quarter, investors track PDEX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PDEX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PDEX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PDEX earnings · 5 questionsPro-Dex, Inc.'s next earnings report is expected around September 1, 2026. PDEX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PDEX historically reports after market close (AMC).
PDEX earnings datewhen is PDEX earningsPDEX next earnings datewhen does PDEX report earningsPDEX earnings calendar
▸ Source: FMP · Pro-Dex, Inc. SEC filings · US GAAP · Pro-Dex, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026